Skip to main content
News & Events
You are here
In April 2019, Novosanis signed a worldwide, non-exclusive distribution agreement with Fujirebio, a global leader in the field of in vitro diagnostics (IVD), for use of Colli-Pee® with...
Distribuidora Química y Hospitalaria GAP
Novosanis has set-up a distribution agreement with GAP for supply of its Colli-Pee device in Mexico. GAP is a young and enterprising Mexican company, dedicated to the commercialization and...
Novosanis supplies its Colli-Pee device to Diagnolita as part of their convenience kit for detection of prostate cancer. Diagnolita is based in Lithuania.
Novosanis has signed an agreement with MDxHealth to supply UrNCollect ™ , a customized version of the company’s patented urine collection device called Colli-Pee ™. The medical device...